Conceptus, Inc. (CPTS) Names David H. Chung as New Chief Commercial Officer
8/13/2012 9:07:15 AM
MOUNTAIN VIEW, Calif., Aug. 13, 2012 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS),developer of the Essure® procedure, the leading surgery-free permanent birth control method, announced today that it has appointed medical device industry executive David H. Chung to the newly-created position of Chief Commercial Officer and Executive Vice President, effective immediately. Mr. Chung has more than 20 years of experience building world-class commercial organizations within the field of implantable medical devices. He will lead the Company's global sales and marketing strategies and report directly to Conceptus President and Chief Executive Officer, D. Keith Grossman.
comments powered by